Clinical Trials Browser

Recurrence × apatinib × Lymphoid × Clear all

NCT04476459 2021-03-15

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

Phase 1/2 Unknown

Recurrence, Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic

NCT03376958 2019-07-25

Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma

Phase 4 Completed

Recurrence, Lymphoma, Large B-Cell, Diffuse